Entecavir
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- China
- Brand name
- Trojanpharm
- Payment Terms
- T/T
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- 142217-69-4, entecavir
- Category
- Chemical Reagents & Products
Guangzhou Trojan Pharmatech Ltd
- Verified Certificate
-
10
Product name | Entecavir | Certification | - |
---|---|---|---|
Category | Chemical Reagents & Products | Ingredients | - |
Keyword | 142217-69-4 , entecavir | Unit Size | - |
Brand name | Trojanpharm | Unit Weigh | - |
origin | China | Stock | - |
Supply type | - | HS code | - |
Product Information
Name: Entecavir
CAS: 142217-69-4
Character: white powder or off-white powder
Water: 5.8%-6.5%
Optical rotation: +24.0o-+28.0o (DMF:
MeOH=1:1 c=1%)
Residue on ignition: ≤0.1%
Purity: 99.8%
We are engaged in offering high quality of entecavir to our clients.
B2B Trade
Price (FOB) | Negotiable | transportation | - |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | T/T | Shipping time | Negotiable |
- President
- Mr. Zheng
- Address
- G11 Building, 31 Kefeng Road, South China New Materials Innovation Park , Science town, Guangzhou.
- Product Category
- Organic Intermediate
- Year Established
- 2013
- No. of Total Employees
- 51-100
- Company introduction
-
<p>
Based in China with global outreach, Guangzhou Trojan Pharmtech Ltd is a high-tech pharmaceutical enterprise covering the services of R&D, manufacturing, sales and export trading of APIs (Active Pharmaceutical Ingredient) and pharmaceutical intermediates. The company has also engaged in researching and developing new technologies for pharmaceutical preparations and new drug registration.
Headquartered in Guangzhou Science City, Trojan has set up a research center in International Business Incubator at South China Center for Innovative Pharmaceuticals with the support of Center’s platform of pharmaceutical services. Since the establishment in 2013, Trojan has made progress on a number of projects, some of which has been put into production and filed a Chinese invention patent. With the spirit of "working together to achieve perfection”, the company aims to become a leading domestic pharmaceutical enterprise with global competitiveness.
- Main Markets
-
India
Indonesia
Macao(China)
Malaysia
Pakistan
Philippines
- Main Product